These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32334489)

  • 21. Occurrence of extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria.
    Park YJ; Park SY; Oh EJ; Park JJ; Lee KY; Woo GJ; Lee K
    Diagn Microbiol Infect Dis; 2005 Apr; 51(4):265-9. PubMed ID: 15808318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of derepressed ampC mutants and extended-spectrum beta-lactamase producers among clinical isolates of Citrobacter freundii, Enterobacter spp., and Serratia marcescens in Korea: dissemination of CTX-M-3, TEM-52, and SHV-12.
    Kim J; Lim YM
    J Clin Microbiol; 2005 May; 43(5):2452-5. PubMed ID: 15872281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility of clinical isolates of Serratia marcescens.
    Alvarez JS; Regueiro B; Garrido MJ
    Antimicrob Agents Chemother; 1979 Oct; 16(4):523-4. PubMed ID: 391150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for extended-spectrum beta-lactamase-producing Serratia marcescens and Klebsiella pneumoniae acquisition in a neonatal intensive care unit.
    Crivaro V; Bagattini M; Salza MF; Raimondi F; Rossano F; Triassi M; Zarrilli R
    J Hosp Infect; 2007 Oct; 67(2):135-41. PubMed ID: 17884248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE).
    Pfaller MA; Jones RN; Marshall SA; Coffman SL; Hollis RJ; Edmond MB; Wenzel RP
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):211-9. PubMed ID: 9327251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and characterization of extended spectrum β-lactamases in Klebsiella-Enterobacter-Serratia group bacteria, in Algeria.
    Nedjai S; Barguigua A; Djahmi N; Jamali L; Zerouali K; Dekhil M; Timinouni M
    Med Mal Infect; 2012 Jan; 42(1):20-9. PubMed ID: 22056377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial.
    Morfin-Otero R; Noriega ER; Dowzicky MJ
    Ann Clin Microbiol Antimicrob; 2015 Dec; 14():53. PubMed ID: 26667651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outbreak of infection by extended-spectrum beta-lactamase SHV-5-producing Serratia marcescens in a Mexican hospital.
    Espinosa de los Monteros LE; Silva-Sanchez J; Jiménez LV; Rojas T; Garza-Ramos U; Valverde V
    J Chemother; 2008 Oct; 20(5):586-92. PubMed ID: 19028621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serratia marcescens isolated in 2005 from clinical specimens from patients with diminished immunity.
    Młynarczyk A; Młynarczyk G; Pupek J; Bilewska A; Kawecki D; Łuczak M; Gozdowska J; Durlik M; Paczek L; Chmura A; Rowińnski W
    Transplant Proc; 2007 Nov; 39(9):2879-82. PubMed ID: 18022007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aminoglycoside resistance patterns of Serratia marcescens strains of clinical origin.
    Coria-Jiménez R; Ortiz-Torres C
    Epidemiol Infect; 1994 Feb; 112(1):125-31. PubMed ID: 8119351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of TEM-, SHV- and CTX-M-type β-lactamase production among clinical isolates of Salmonella species.
    Elumalai S; Muthu G; Selvam REM; Ramesh S
    J Med Microbiol; 2014 Jul; 63(Pt 7):962-967. PubMed ID: 24866367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relation of beta-lactamase activity to antimicrobial susceptibility in Serratia marcescens.
    Tsang JC; Sansing GA; Miller MA
    Antimicrob Agents Chemother; 1975 Sep; 8(3):277-81. PubMed ID: 1101819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissemination of cephalosporin-resistant Serratia marcescens strains producing a plasmidic SHV type beta-lactamase in Greek hospitals.
    Gianneli D; Tzelepi E; Tzouvelekis LS; Mentis AF; Nikolopoulou C
    Eur J Clin Microbiol Infect Dis; 1994 Sep; 13(9):764-7. PubMed ID: 7843183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of cefotaxime-resistant CTX-M-3 in clinical isolates of Serratia marcescens.
    Tsou MF; Yu WL; Hung SW; Chi CJ; Chieh-Ju ; Chen SC; Wu LT
    Folia Microbiol (Praha); 2004; 49(4):452-6. PubMed ID: 15530012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CTX-M and TEM as predominant types of extended spectrum beta-lactamases among Serratia marcescens isolated from solid organ recipients.
    Mlynarczyk A; Szymanek K; Sawicka-Grzelak A; Pazik J; Buczkowska T; Durlik M; Lagiewska B; Pacholczyk M; Chmura A; Paczek L; Mlynarczyk G
    Transplant Proc; 2009 Oct; 41(8):3253-5. PubMed ID: 19857723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic susceptibility of Serratia marcescens and Serratia liquefaciens.
    Traub WH
    Chemotherapy; 2000; 46(5):315-21. PubMed ID: 10965096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nosocomial strain of Serratia marcescens producing a new type of extended spectrum beta-lactamase transfers multidrug resistance.
    Babalova M; Blahova J; Kralikova K; Krcmery V; Jezek P; Rovny I
    J Chemother; 2006 Jun; 18(3):334-5. PubMed ID: 17129849
    [No Abstract]   [Full Text] [Related]  

  • 38. KPC-PRODUCING Serratia marcescens IN A HOME-CARE PATIENT FROM RECIFE, BRAZIL.
    Margate E; Magalhães V; Fehlberg LC; Gales AC; Lopes AC
    Rev Inst Med Trop Sao Paulo; 2015; 57(4):359-60. PubMed ID: 26422164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term spatiotemporal variation of antimicrobial resistance genes within the Serratia marcescens population and transmission of S. marcescens revealed by public whole-genome datasets.
    Hou J; Mao D; Zhang Y; Huang R; Li L; Wang X; Luo Y
    J Hazard Mater; 2022 Feb; 423(Pt B):127220. PubMed ID: 34844350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Genes of resistance to aminoglycoside antibiotics in clinical strains of Serratia marcescens and the enzyme encoded by them].
    Kolganov AN; Vakulenko SB
    Antibiot Khimioter; 1992 Nov; 37(11):10-4. PubMed ID: 1300924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.